EDGAR Filing Documents for 0001437749-17-005108

Form 8-K - Current report:

SEC Accession No. 0001437749-17-005108

Filing Date

2017-03-23

Accepted

2017-03-23 09:09:42

Documents

Period of Report

2017-03-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	idxg20170322_8k.htm	8-K	62076
2	EXHIBIT 4.1	ex4-1.htm	EX-4.1	152076
3	EXHIBIT 4.2	ex4-2.htm	EX-4.2	279874
4	EXHIBIT 4.3	ex4-3.htm	EX-4.3	86617
5	EXHIBIT 10.1	ex10-1.htm	EX-10.1	286612
6	EXHIBIT 10.5	ex10-5.htm	EX-10.5	43494
7	EXHIBIT 99.1	ex99-1.htm	EX-99.1	18954
8		image.jpg	GRAPHIC	5697
	Complete submission text file	0001437749-17-005108.txt		939330

Mailing Address MORRIS CORPORATE CENTER 1, BUILDING A, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054

Business Address MORRIS CORPORATE CENTER 1, BUILDING A, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 (855) 776-6419

Interpace Diagnostics Group, Inc. (Filer) CIK: 0001054102 (see all company filings)